Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as a sterile intravenous solution for intravenous use. It reduces gastric acid secretion and is employed in the management of acid‑related disorders such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and for ulcer prophylaxis in patients receiving non‑steroidal anti‑inflammatory drugs.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nexium (esomeprazole) is indicated for several acid‑related conditions that involve excessive gastric acid production.

- Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates mucosal repair and alleviates symptoms. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations. - Prevention of NSAID‑associated gastric ulcers: provides protective acid suppression for at‑risk patients.

Esomeprazole may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often reported during therapy. - Diarrhea: loose stools that may occur early in treatment. - Nausea: transient feeling of queasiness. - Abdominal pain: discomfort in the upper abdomen.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Severe allergic reactions (anaphylaxis): rash, swelling, and breathing difficulty. - Hypomagnesemia: low serum magnesium with prolonged use.

When prescribing Nexium, clinicians should consider several precautionary measures to minimise risk.

- Assess renal function: dose adjustment may be required in severe renal impairment. - Monitor magnesium levels: prolonged therapy can lead to hypomagnesemia. - Review concomitant drugs that need gastric acidity for absorption. - Use caution in hepatic impairment: monitor liver function tests. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Esomeprazole can alter the pharmacokinetics of several concomitant medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid): - Ketoconazole: reduced absorption and efficacy. - Atazanavir: decreased plasma concentrations. - Clopidogrel: diminished activation and antiplatelet effect. - Warfarin: potential increase in INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: possible increase in serum levels. - Methotrexate: reduced renal clearance leading to higher exposure. - Phenytoin: may increase metabolism of esomeprazole, lowering its effect.